Involving the community in research to improve preparedness for the next pandemic

The next pandemic of an infectious disease could start tomorrow. The involvement of communities in research that is relevant to their lives is our solution to improve public understanding of infectious diseases and preparation for the next pandemic.

The next pandemic of an infectious disease could start tomorrow. Every day, millions of people wake up, go to work, drop their children off at school, and enjoy leisure time with family and friends, following daily routines and schedules. However, when the unexpected does happen, routines change drastically, and people are suddenly aware of how fragile our lives can be. The ongoing coronavirus disease 2019 (COVID-19) pandemic showed us that inadequate preparation resulted in a crisis of rapid global spread, lockdowns that stopped daily activities and caused more than thirteen thousand deaths in Switzerland (millions worldwide).[1][2] The involvement of communities in research that is relevant to their lives is our solution to improve public understanding of infectious diseases and preparation for the next pandemic.

Epidemics and pandemics are leading threats to global health security.[3] And other threats, such as climate change and globalisation, make it more likely that pathogens, such as avian influenza, HIV, severe acute respiratory syndrome coronaviruses (SARS-CoV-2 causes COVID-19), and now monkeypox, will emerge or re-emerge. Pandemics affect not only people’s health and well-being, they also have a massive impact on all aspects of society and the economy, including trade, food production, travel and education. When services and employment are disrupted, livelihoods are turned upside down. An important way to reduce these negative effects is preparedness. The term ‘preparedness’ refers to the ability of governments, professional organisations (including universities), communities and individuals to put in place mechanisms to anticipate and respond effectively to the impact of likely, imminent or current hazards, events or conditions.[4] Preparedness must include action at the community level and in the settings in which people spend their daily activities, where they live, work, play, and love.

We will need to prepare and involve communities to navigate the crisis. By increasing the speed and quality of assistance, preparedness can make a major difference in adapting response measures, which can save lives and reduce suffering.

What is the role for research?

Research studies that aim to improve preparedness have to be set up and running before the start of a pandemic. When the COVID-19 pandemic started, some of our earliest insights into how SARS-CoV-2 was affecting Switzerland came from existing research studies that were adapted quickly. By contacting former participants of a study about diabetes,[5] investigators in Geneva created a new study that showed that by May 2020, most of the Swiss population was still susceptible to COVID-19.[6] That study has continued to provide knowledge about COVID-19,[7][8] but it was not set up to study infectious diseases. In the United Kingdom, researchers who studied patterns of social contact before SARS-CoV-2 arrived[9][10] could rapidly help to understand which interventions could prevent SARS-CoV-2 transmission.[11][12] Those studies did not, however, collect samples that could be tested for infection.

Our team at the Multidisciplinary Center for Infectious Diseases, University of Bern is setting up a participatory cohort study called BEready (“Bern, get ready”), which means involving community members at all phases of the research and following a defined group of households in the Canton of Bern over time. The BEready study will address gaps in research about pandemic preparedness in three ways: a) raising awareness in civil society about the importance of preparedness for future pandemics, b) collection of essential data, including samples, to characterise the Bernese population, their knowledge and views about infectious diseases, and c) when the next pandemic pathogen spreads to Switzerland, BEready participants will be ready to take part in research projects that will improve our understanding of the new disease and contribute to implementation of preventive measures.

New cohort studies like BEready, which investigate infectious diseases, can incorporate plans for deployment of specific studies in future pandemics.[13][14] Experts in pandemic preparedness strongly recommend the establishment of such cohorts[15], which can foster active ongoing communication to promote public engagement in infectious diseases research and provide a platform that can pivot rapidly to launch essential studies to gain early understanding about newly emerging infectious diseases. The timing of emergence and the route of transmission of pandemic-causing pathogens is not known so BEready will collect different types of information from participants. We will also collect samples, for example swabs like those for COVID-19 tests and conduct laboratory analyses. Over time, we will be able to examine trends in exposure to specific infections and factors associated with them.

We plan to enrol a random sample of around 1,500 households across the Canton of Bern, including adults, children and household pets during 2023-24. Community members will co develop meaningful and relevant research questions, promote the cohort study in their personal networks and relevant communities, and contribute to the enrollmentenrolment of households, collection of data, and to making sense of the findings. We will jointly develop recommendations for action. Community engagement will range from peer-researchers, staff, advisory and consultation boards to community champions and promoters. Regular public outreach events will be set up to inform households about activities of BEready, findings from the research and recommendations for actions to be taken at community and policy level. 

Diese und viele weitere Ideen werden in der Blogposts Reihe zum Reatch Ideenwettbewerb 2022 präsentiert.

Who is needed as a partner?

We are still preparing the BEready cohort. The key to the success of sustainable participation is early engagement with the public, politicians and other stakeholders. Involving these actors, building a BEready community and maximising visibility, will be key to the success of our project.

We want the people in the Canton of Bern to claim BEready as their cohort, wanting to ask relevant and meaningful questions, to succeed, feel proud of being part of it, lobby for it in a bottom-up/grassroots manner, and actively help to shape it. Partners in civil society can help galvanise other community members, so we will involve people from the canton as peer researchers as well as cohort promoters in their networks and communities. Public involvement and engagement will result in better (i.e., more relevant) data and a population more aware of the importance of and actively seeking preparedness. If politicians, media and the general population feel ownership of BEready, they will actively contribute to its success and also ensure that cohort members remain in the cohort.

In addition to the public, who will be central for our idea, the following actors are needed.

Government and parliament can amplify our message and support policies that will promote a favourable environment for such a pandemic preparedness cohort. Broad buy-in from politicians will help us to get the population involved. A close collaboration with policy makers could foster joint projects to answering policy-relevant questions around pandemic preparedness.

The media are essential in getting the word out there. Their messaging will shape people’s opinion. They can contribute to an ongoing open discussion of people’s expectations and concerns surrounding the cohort and promote continued improvements.

The value of the cohort will be greatest when a new pandemic starts to emerge. In-between pandemics it may be more difficult to convince donors and public funding bodies of the importance of maintaining the cohort’s infrastructure as priorities may shift to other research areas. Hence the support of foundations and businesses who commit to altruistic long-term funding will ensure the cohort can be maintained.

Academic partners will be able to propose their own research questions and apply for data access and additional data collection. Collaborative research will ensure that the BEready cohort answers relevant scientific questions about pandemic preparedness from across all scientific disciplines.

When the next pandemic arrives, the BEready cohort and community will be prepared and will take part in studies that provide essential information to prevent a crisis.

Auch dieses Jahr suchen wir im Rahmen des Ideenwettbewerbs wieder deine Ideen für die Zukunft!

Das Bewerbungsfenster für den diesjährigen Reatch Ideenwettbewerb ist geöffnet und wir suchen Ideen, wie die Wissenschaften mit der Politik, der Wirtschaft oder der Zivilgesellschaft in den nächsten 175 Jahren gemeinsam Herausforderungen unserer Gesellschaft meistern können.

Alle Informationen zum Ideenwettbewerb 2023 findest du hier.



The Independent Panel for Pandemic Preparedness & Response. COVID-19: Make It the Last Pandemic.; 2021. Accessed September 9, 2022. https://theindependentpanel.or... Last-Pandemic_final.pdf


Sachs JD, Karim SSA, Aknin L, et al. The Lancet Commission on lessons for the future from the COVID-19 pandemic. The Lancet. 2022; 400(10359):1224-1280. doi:10.1016/S0140-6736(22)01585-9


World Health Organization. Ten Threats to Global Health in 2019. threats-to-global-health-in-2019. Published online 2019.


United Nations Office for the Coordination of Humanitarian Affairs (OCHA). What is preparedness? https://www.humanitarianrespon.... Published online 2016.


Morabia A, Bernstein M, Héritier S, Ylli A. Community-based surveillance of cardiovascular risk factors in Geneva: methods, resulting distributions, and comparisons with other populations. Prev Med. 26(3):311-319. doi:10.1006/pmed.1997.0146


Stringhini S, Wisniak A, Piumatti G, et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. Lancet. 2020;396(10247):313-319. doi:10.1016/S0140- 6736(20)31304-0


Stringhini S, Zaballa ME, Perez-Saez J, et al. Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak. Lancet Infect Dis. 2021;21(5):600-601. doi:10.1016/S1473-3099(21)00054-2


Richard A, Wisniak A, Perez-Saez J, et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies, risk factors for infection and associated symptoms in Geneva, Switzerland: a population-based study. Scand J Public Health. 2022;50(1):124-135. doi:10.1177/14034948211048050


Hens N, Ayele GM, Goeyvaerts N, et al. Estimating the impact of school closure on social mixing behaviour and the transmission of close contact infections in eight European countries. BMC Infect Dis. 2009;9(1):187. doi:10.1186/1471-2334-9-187


Mossong J, Hens N, Jit M, et al. Social Contacts and Mixing Patterns Relevant to the Spread of Infectious Diseases. PLoS Med. 2008;5(3):e74. doi:10.1371/journal.pmed.0050074


Jarvis CI, van Zandvoort K, Gimma A, et al. Quantifying the impact of physical distance measures on the transmission of COVID-19 in the UK. BMC Med. 2020;18(1):124. doi:10.1186/s12916-020-01597-8


Hellewell J, Abbott S, Gimma A, et al. Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts. Lancet Glob Health. 2020;8(4):e488-e496. doi:10.1016/S2214-109X(20)30074-7


Fragaszy EB, Warren-Gash C, Wang L, et al. Cohort Profile: The Flu Watch Study. Int J Epidemiol. Published online March 3, 2016:dyv370. doi:10.1093/ije/dyv370


Cohen C, McMorrow ML, Martinson NA, et al. Cohort profile: A Prospective Household cohort study of Influenza, Respiratory syncytial virus and other respiratory pathogens community burden and Transmission dynamics in South Africa, 2016–2018. Influenza Other Respir Viruses. 2021;15(6):789-803. doi:10.1111/irv.12881


Norton A, Sigfrid L, Aderoba A, et al. Preparing for a pandemic: highlighting themes for research funding and practice—perspectives from the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R). BMC Med. 2020;18(1):273. doi:10.1186/s12916-020-01755-y

Dieser Text ist im Rahmen des Reatch Ideenwettbewerbs entstanden. Um die Krisen von morgen zu meistern, brauchen wir als Gesellschaft Vorstellungsvielfalt als Rüstzeug. Dafür notwendig ist ein gemeinsames Verständnis, aber auch konkrete Ideen und Ansätze, wie Probleme angegangen und gelöst werden können. Dieses Ziel verfolgt der Reatch Ideenwettbewerb. Im Rahmen davon, haben wir nach Ideen gesucht, wie die Wissenschaften zusammen mit Politik, Wirtschaft oder Gesellschaft die Krisen von morgen meistern können. Denn eine enge und konstruktive Zusammenarbeit zwischen den verschiedenen Akteuren ist entscheidend, damit wissenschaftliche Erkenntnisse auch Eingang in politische und gesellschaftliche Lösungen finden. Der Ideenwettbewerb wurde u.a. unterstützt durch die Stiftung Mercator Schweiz, die Gebert Rüf Stiftung und den Schweizerischen Nationalfonds (SNF).

Das Franxini-Projekt: Wir wollen eine Gesellschaft, in der Akteure aus Wissenschaften und Politik zusammenarbeiten, um gesellschaftliche Herausforderungen effektiv zu bewältigen. Dank dem politischen Engagement von Forschenden aus allen Fachrichtungen tragen wissenschaftlich fundierte Ideen zu effektiven Lösungen bei, von denen die ganze Gesellschaft profitiert.

Das Franxini-Projekt ist entstanden auf Initiative der wissenschaftlichen Ideenschmiede «Reatch! Research. Think. Change.» und wird unterstützt von einer Reihe von renommierten Persönlichkeiten aus Wissenschaften, Politik und Gesellschaft und wird gefördert von der Stiftung Mercator, der Gebert Rüf Stiftung, der cogito foundation, der Universität Zürich, dem ETH Rat, der Akademie der Naturwissenschaften Schweiz und weiteren Partnern.


Projektmanagerin für die «Bern, get ready» (BEready) Kohortenstudie, Universität Bern. Ich bin Pharmazeutin und Epidemiologin und suche Lösungen zur Bekämpfung von Infektionskrankheiten. Ich liebe den Austausch mit anderen Menschen und möchte helfen, den Grundstein für eine erfolgreiche Zusammenarbeit mit der Politik zur besseren Vorbereitung auf die nächste Pandemie zu legen.


Professorin für Epidemiologie und Public Health, Institut für Sozial- und Präventivmedizin, Universität Bern. Ich bin Medizinerin und Epidemiologin. Meine Leidenschaft gilt der Forschung über Infektionskrankheiten, öffentliche Gesundheit und Pandemien.

Die Beiträge auf dem Reatch-Blog geben die persönliche Meinung der Autor*innen wieder und entsprechen nicht zwingend derjenigen von Reatch oder seiner Mitglieder.

Zum Kommentieren mehr als 20 Zeichen im Text markieren und Sprechblase anklicken.

Wir freuen uns über nützliche Anmerkungen. Die Kommentare werden moderiert.